
Abigail Louise Vanhorn
Examiner (ID: 11338)
| Most Active Art Unit | 1616 |
| Art Unit(s) | 1616, 1636, 1609 |
| Total Applications | 1393 |
| Issued Applications | 581 |
| Pending Applications | 145 |
| Abandoned Applications | 710 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17256928
[patent_doc_number] => 20210369913
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-02
[patent_title] => SUSTAINED RELEASE INJECTABLE FORMULATION CONTAINING A POLY L LACTIC ACID FILLER AND A HYALURONIC ACID FILLER CONJUGATE AND A METHOD FOR PREPARING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/057924
[patent_app_country] => US
[patent_app_date] => 2020-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3748
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 181
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17057924
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/057924 | Sustained release injectable formulation containing a poly L lactic acid filler and a hyaluronic acid filler conjugate and a method for preparing the same | Nov 5, 2020 | Issued |
Array
(
[id] => 18143083
[patent_doc_number] => 20230016929
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-19
[patent_title] => EXTRAHEPATIC DELIVERY
[patent_app_type] => utility
[patent_app_number] => 17/774477
[patent_app_country] => US
[patent_app_date] => 2020-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 85020
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17774477
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/774477 | EXTRAHEPATIC DELIVERY | Nov 5, 2020 | Pending |
Array
(
[id] => 18293863
[patent_doc_number] => 20230103549
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-06
[patent_title] => OVERLAPPING THERAPEUTIC STRATEGIES FOR CYSTINOSIS TREATMENT AND COSMETIC SKIN DARKENING
[patent_app_type] => utility
[patent_app_number] => 17/771808
[patent_app_country] => US
[patent_app_date] => 2020-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25709
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17771808
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/771808 | OVERLAPPING THERAPEUTIC STRATEGIES FOR CYSTINOSIS TREATMENT AND COSMETIC SKIN DARKENING | Oct 24, 2020 | Pending |
Array
(
[id] => 17865479
[patent_doc_number] => 20220288214
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-15
[patent_title] => CONJUGATES AND METHODS FOR TREATING ACROMEGALY
[patent_app_type] => utility
[patent_app_number] => 17/770504
[patent_app_country] => US
[patent_app_date] => 2020-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14117
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17770504
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/770504 | CONJUGATES AND METHODS FOR TREATING ACROMEGALY | Oct 22, 2020 | Pending |
Array
(
[id] => 16718460
[patent_doc_number] => 20210085607
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-25
[patent_title] => CONTINUOUS MICROPARTICLE MANUFACTURE
[patent_app_type] => utility
[patent_app_number] => 17/077856
[patent_app_country] => US
[patent_app_date] => 2020-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35008
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -35
[patent_words_short_claim] => 123
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17077856
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/077856 | CONTINUOUS MICROPARTICLE MANUFACTURE | Oct 21, 2020 | Abandoned |
Array
(
[id] => 16777993
[patent_doc_number] => 20210115071
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-22
[patent_title] => NANOSCALE METAL-ORGANIC FRAMEWORKS FOR ENHANCED TUMOR CHEMORADIATION
[patent_app_type] => utility
[patent_app_number] => 17/072895
[patent_app_country] => US
[patent_app_date] => 2020-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19026
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17072895
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/072895 | NANOSCALE METAL-ORGANIC FRAMEWORKS FOR ENHANCED TUMOR CHEMORADIATION | Oct 15, 2020 | Abandoned |
Array
(
[id] => 18970277
[patent_doc_number] => 20240050369
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-15
[patent_title] => Targeted Nanomedicine for Treating Vascular Disorders
[patent_app_type] => utility
[patent_app_number] => 17/766318
[patent_app_country] => US
[patent_app_date] => 2020-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10353
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17766318
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/766318 | Targeted Nanomedicine for Treating Vascular Disorders | Oct 4, 2020 | Pending |
Array
(
[id] => 16627452
[patent_doc_number] => 20210046105
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-18
[patent_title] => COMPOSITIONS AND METHODS FOR TARGETING CELLS
[patent_app_type] => utility
[patent_app_number] => 17/035339
[patent_app_country] => US
[patent_app_date] => 2020-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20129
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17035339
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/035339 | Compositions and methods for targeting cells | Sep 27, 2020 | Issued |
Array
(
[id] => 17930156
[patent_doc_number] => 20220325281
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-13
[patent_title] => OLIGONUCLEOTIDE, AND TARGET RNA SITE-SPECIFIC EDITING METHOD
[patent_app_type] => utility
[patent_app_number] => 17/754196
[patent_app_country] => US
[patent_app_date] => 2020-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8610
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 135
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17754196
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/754196 | OLIGONUCLEOTIDE, AND TARGET RNA SITE-SPECIFIC EDITING METHOD | Sep 24, 2020 | Pending |
Array
(
[id] => 18314126
[patent_doc_number] => 11628186
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-04-18
[patent_title] => Method and composition for the reduction of viral replication, duration and spread of the COVID-19 and the flu
[patent_app_type] => utility
[patent_app_number] => 16/974068
[patent_app_country] => US
[patent_app_date] => 2020-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30116
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 162
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16974068
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/974068 | Method and composition for the reduction of viral replication, duration and spread of the COVID-19 and the flu | Sep 20, 2020 | Issued |
Array
(
[id] => 16748168
[patent_doc_number] => 20210100177
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-08
[patent_title] => Horticulture Additive
[patent_app_type] => utility
[patent_app_number] => 17/024755
[patent_app_country] => US
[patent_app_date] => 2020-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6043
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17024755
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/024755 | Horticulture Additive | Sep 17, 2020 | Abandoned |
Array
(
[id] => 16806237
[patent_doc_number] => 20210128790
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-06
[patent_title] => CLICK-CROSSLINKED HYDROGELS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/022062
[patent_app_country] => US
[patent_app_date] => 2020-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11927
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17022062
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/022062 | Click-crosslinked hydrogels and methods of use | Sep 14, 2020 | Issued |
Array
(
[id] => 18034705
[patent_doc_number] => 20220378920
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-01
[patent_title] => CONJUGATE OF GalNAc-OLIGONUCLEOTIDE FOR DELIVERY TO LIVER AND MANUFACTURING METHOD THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/641741
[patent_app_country] => US
[patent_app_date] => 2020-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26888
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17641741
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/641741 | CONJUGATE OF GalNAc-OLIGONUCLEOTIDE FOR DELIVERY TO LIVER AND MANUFACTURING METHOD THEREOF | Sep 8, 2020 | Pending |
Array
(
[id] => 17947114
[patent_doc_number] => 20220334133
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-20
[patent_title] => METHODS AND COMPOUNDS MODIFYING MITOCHONDRIAL FUNCTION
[patent_app_type] => utility
[patent_app_number] => 17/640764
[patent_app_country] => US
[patent_app_date] => 2020-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27288
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -43
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17640764
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/640764 | METHODS AND COMPOUNDS MODIFYING MITOCHONDRIAL FUNCTION | Sep 3, 2020 | Pending |
Array
(
[id] => 16512805
[patent_doc_number] => 20200392063
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-17
[patent_title] => LABILE ESTERS OF AGROCHEMICALS FOR CONTROLLED RELEASE AND REDUCTION OF OFF-SITE MOVEMENT
[patent_app_type] => utility
[patent_app_number] => 17/008880
[patent_app_country] => US
[patent_app_date] => 2020-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20195
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17008880
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/008880 | Labile esters of agrochemicals for controlled release and reduction of off-site movement | Aug 31, 2020 | Issued |
Array
(
[id] => 16671452
[patent_doc_number] => 20210060215
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-04
[patent_title] => MEDICAL DEVICES FOR CONTINUOUS DELIVERY OF THERAPEUTIC AGENTS
[patent_app_type] => utility
[patent_app_number] => 17/003361
[patent_app_country] => US
[patent_app_date] => 2020-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18154
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17003361
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/003361 | Medical devices for continuous delivery of therapeutic agents | Aug 25, 2020 | Issued |
Array
(
[id] => 16671192
[patent_doc_number] => 20210059955
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-04
[patent_title] => SYSTEMS AND METHODS FOR DECRYSTALLIZATION OF URIC ACID
[patent_app_type] => utility
[patent_app_number] => 17/000450
[patent_app_country] => US
[patent_app_date] => 2020-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9349
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17000450
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/000450 | SYSTEMS AND METHODS FOR DECRYSTALLIZATION OF URIC ACID | Aug 23, 2020 | Abandoned |
Array
(
[id] => 16673241
[patent_doc_number] => 20210062004
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-04
[patent_title] => RADIOPAQUE MULTI-ARMED POLYMERS AND COMPOSITIONS, SYSTEMS AND METHODS PERTAINING TO THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/999841
[patent_app_country] => US
[patent_app_date] => 2020-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4460
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16999841
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/999841 | Radiopaque multi-armed polymers and compositions, systems and methods pertaining to the same | Aug 20, 2020 | Issued |
Array
(
[id] => 17851869
[patent_doc_number] => 20220281911
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-08
[patent_title] => OLIGONUCLEOTIDE CONJUGATE COMPOSITIONS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/636437
[patent_app_country] => US
[patent_app_date] => 2020-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33228
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -40
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17636437
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/636437 | OLIGONUCLEOTIDE CONJUGATE COMPOSITIONS AND METHODS OF USE | Aug 18, 2020 | Pending |
Array
(
[id] => 16657735
[patent_doc_number] => 20210054371
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-25
[patent_title] => Conjugates of Guide RNA-Cas Protein Complex
[patent_app_type] => utility
[patent_app_number] => 16/994660
[patent_app_country] => US
[patent_app_date] => 2020-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16675
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16994660
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/994660 | Conjugates of Guide RNA-Cas Protein Complex | Aug 16, 2020 | Pending |